Environmental Polymorphisms Registry Health and Exposures Survey
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The Environmental Polymorphisms Registry (EPR) Health and Exposure Survey is designed to gather health, family history of disease, environmental exposures and lifestyle data on adult EPR subjects. The EPR is a registry established to collect and store DNA samples from 20,000 volunteers from North Carolina and to serve as a resource to scientist investigating genotype-driven translational research of chronic conditions. Under this new protocol, we will administer a health and exposures survey to all EPR subjects. The information collected in the survey will be used to better characterize the EPR population thus making it more useful to NIEHS researchers. The survey contains approximately 200 questions. Data from the survey will help researchers develop hypotheses, design follow-up studies, and select appropriate subjects.
The survey will be administered to EPR subjects using a modified version of the Dillman Total Design Method (TDM) for surveys. This method requires following specific time-dependent steps for survey administration that incorporate both self- and phone administration and other types of phone and mail contact. The goal of TDM is to maximize subject response rates.
| Condition |
|---|
|
Diabetes Heart Disease Asthma |
| Study Type: | Observational |
| Study Design: | Time Perspective: Retrospective |
| Official Title: | Environmental Polymorphisms Registry Health and Exposures Survey |
| Estimated Enrollment: | 20000 |
| Study Start Date: | August 2012 |
The Environmental Polymorphisms Registry (EPR) Health and Exposure Survey is designed to gather health, family history of disease, environmental exposures and lifestyle data on adult EPR subjects. The EPR is a registry established to collect and store DNA samples from 20,000 volunteers from North Carolina and to serve as a resource to scientist investigating genotype-driven translational research of chronic conditions. Under this new protocol, we will administer a health and exposures survey to all EPR subjects. The information collected in the survey will be used to better characterize the EPR population thus making it more useful to NIEHS researchers. The survey contains approximately 200 questions. Data from the survey will help researchers develop hypotheses, design follow-up studies, and select appropriate subjects.
The survey will be administered to EPR subjects using a modified version of the Dillman Total Design Method (TDM) for surveys. This method requires following specific time-dependent steps for survey administration that incorporate both self- and phone administration and other types of phone and mail contact. The goal of TDM is to maximize subject response rates.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
- ELIGIBILITY CRITERIA:
There are no clinical exclusion criteria for this Survey. All subjects will be administered the Survey regardless of having clinical conditions.
Contacts and Locations| Contact: Stavros Garantziotis, M.D. | Not Listed | garantziotis@mail.nih.gov |
| Contact: Shepherd H Schurman, M.D. | (919) 541-7736 | schurmansh@mail.nih.gov |
| United States, North Carolina | |
| NIEHS Clinical Research Unit (CRU) | Recruiting |
| Research Triangle Park, North Carolina, United States | |
| Principal Investigator: | Shepherd H Schurman, M.D. | National Institute of Environmental Health Sciences (NIEHS) |
More Information
Additional Information:
No publications provided
| ClinicalTrials.gov Identifier: | NCT01688986 History of Changes |
| Other Study ID Numbers: | 120194, 12-E-0194 |
| Study First Received: | September 14, 2012 |
| Last Updated: | May 1, 2013 |
| Health Authority: | United States: Federal Government |
Keywords provided by National Institutes of Health Clinical Center (CC):
|
Complex Disease DNA Biorepository Genotype-Phenotype Correlation Genetics Environmental Factors |
Additional relevant MeSH terms:
|
Heart Diseases Asthma Bronchial Diseases Respiratory Tract Diseases Lung Diseases, Obstructive Lung Diseases |
Respiratory Hypersensitivity Hypersensitivity, Immediate Hypersensitivity Immune System Diseases Cardiovascular Diseases |
ClinicalTrials.gov processed this record on May 19, 2013